SPOTLIGHT -
How Big Data Can Drive Advancements in MS Research
Big data is on the precipice of revolutionizing multiple sclerosis knowledge and treatment.
Data Evolution in Alzheimer Disease: Is the Future Digital?
Digital biomarkers offer promise to revolutionize the diagnosis and treatment of Alzheimer disease via our increasing ability to gather active and passive data.
Stimulating the Future of Treating Sleep-Disordered Breathing
Addressing sleep apnea at a physiological level may reasonably be more effective and have fewer adverse effects than more traditional treatment modalities that may only target one mechanism.
Unraveling Autoimmune Epilepsy
Could expanding insights into the pathophysiology of autoimmune epilepsy offer seizure-free hope for patients?
The Road to Accessible Biomarkers for Alzheimer Disease
Biomarkers in the cerebrospinal fluid and blood could hold the key to early diagnosis of Alzheimer disease.
Neuromodulation Holds Promise in Alzheimer Disease
Will ethical considerations and lack of consent stand in the way of thoroughly exploring the potential of this nondrug therapy?
Exploring the Potential of Immunotherapy for Movement Disorders
A greater understanding of the role of the immune system in movement disorders may illuminate a path to treatments that target the central causes of disease.
Seeking the True Pathogenesis of Alzheimer Disease
Bogged down by a decades-long chase for a common pathology, investigators exploring alternative and complimentary theories are pushing to extend their time in the spotlight.
The Future of Focused Ultrasound: Movement Disorders and Beyond
The implementation of focused ultrasound has been practice changing in tremor, but the various arenas in which this technology can be used opens up new treatment avenues for a range of neurological disorders.
Gene Therapy Ushers in an Era of Hope for Rare Disorders
Preclinical trials and success stories suggest that much is riding on vector-based therapies for the treatment of rare neurological conditions.